
A Drug “sur-mesures”: Immunotherapy and the Rise of Personalized Medicine
Published at : December 06, 2021
8:30AM PT, 5:30PM GMT - Opening Remarks
Frédéric Jung - Consul General of France in San Francisco
Nevan Krogan - Director of Quantitative Biosciences Institute
Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US
8:45AM PT, 5:45PM GMT - A Drug “Sur-mesures”: immunotherapy and the rise of personalized medicine
Immunotherapy is becoming a more and more mature approach for curing a wide range of ailments, from cancers to auto-immune diseases. It is usually based on highly personalized treatments for specific markers and targets. In this panel, specialists will explain how its rise comes from the successful and powerful combination of several disciplines: immunology, statistical analysis, and computer science to name a few.
Moderator: Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US
Aude Chapuis - Associate Professor, Program in Immunology - Clinical Research Division; John C. and Karyl Kay Hughes Endowed Chair, Fred Hutchinson
Julien Mamet - Founder, CSO and Board Member at Adynxx, Inc
Frédéric Jung - Consul General of France in San Francisco
Nevan Krogan - Director of Quantitative Biosciences Institute
Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US
8:45AM PT, 5:45PM GMT - A Drug “Sur-mesures”: immunotherapy and the rise of personalized medicine
Immunotherapy is becoming a more and more mature approach for curing a wide range of ailments, from cancers to auto-immune diseases. It is usually based on highly personalized treatments for specific markers and targets. In this panel, specialists will explain how its rise comes from the successful and powerful combination of several disciplines: immunology, statistical analysis, and computer science to name a few.
Moderator: Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US
Aude Chapuis - Associate Professor, Program in Immunology - Clinical Research Division; John C. and Karyl Kay Hughes Endowed Chair, Fred Hutchinson
Julien Mamet - Founder, CSO and Board Member at Adynxx, Inc

“sur-mesures”:ImmunotherapyPersonalized